T. Rowe Price Associates
SGFY

T. Rowe Price Associates’s Signify Health, Inc. SGFY Stock Holding History

T. Rowe Price Associates’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,537
Closed -$646K – 2977
2022
Q4 		$646K Buy
22,537
+7,283
+48% +$210K ﹤0.01% 2009
2022
Q3 		$445K Buy
15,254
+1,688
+12% +$38.9K ﹤0.01% 2177
2022
Q2 		$187K Sell
13,566
-4,681
-26% -$65.9K ﹤0.01% 2624
2022
Q1 		$331K Sell
18,247
-1,291
-7% -$18.5K ﹤0.01% 2516
2021
Q4 		$278K Buy
+19,538
New +$302K ﹤0.01% 2623

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

T. Rowe Price Associates's SGFY Position: Q1 2023 in Review

T. Rowe Price Associates sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 22,537 shares — an estimated $646K sold.

T. Rowe Price Associates first reported a position in SGFY in Q4 2021 and held it in 5 quarters. The position peaked at $646K in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • T. Rowe Price Associates reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 22,537 Signify Health, Inc. shares in Q1 2023, an estimated $646K.
  • T. Rowe Price Associates first reported a position in Signify Health, Inc. in Q4 2021 and held it in 5 quarters.
  • T. Rowe Price Associates's Signify Health, Inc. position peaked at $646K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.